March 02, 2015 10:33 PM ET

Biotechnology

Company Overview of miRagen Therapeutics, Inc.

Key Executives for miRagen Therapeutics, Inc.

NameBoard RelationshipsTitleAge
William S. Marshall Ph.D.31 RelationshipsCo-Founder, Chief Executive Officer, President and Director--
Bruce L. Booth D.Phil., Ph.D.88 RelationshipsCo-Founder and Chairman of The Board 40
Michael R. Bristow M.D., Ph.D.22 RelationshipsCo-Founder and Member of the Scientific Advisory Board69
Marvin H. Caruthers Ph.D.48 RelationshipsCo-Founder and Director74
Eric N. Olson Ph.D.61 RelationshipsCo-Founder and Member of Scientific Advisory Board--
View More Key Executives

miRagen Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Bruce L. Booth D.Phil., Ph.D. 88 RelationshipsRodin Therapeutics Inc.40
William S. Marshall Ph.D. 31 RelationshipsmiRagen Therapeutics, Inc.--
Eric N. Olson Ph.D. 61 RelationshipsmiRagen Therapeutics, Inc.--
Michael R. Bristow M.D., Ph.D. 22 RelationshipsARCA biopharma, Inc.69
Marvin H. Caruthers Ph.D. 48 RelationshipsmiRagen Therapeutics, Inc.74
View All Board Members

miRagen Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
318.3K
Bonus
185.3K
Total Short Term Compensation
386.4K
Total Value of Options
3.0M
Compensation as of Fiscal Year
miRagen Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

SCA Announces Executive Changes
March 02, 2015 7:07 AM ET
SCA Appoints Linda Nyberg as Vice President of Media Relations and Online Communications
February 26, 2015 12:00 AM ET
Hipolin Limited Announces Management Appointments
February 23, 2015 10:19 AM ET
Harbinger Group Inc. Appoints Curtis Glovier as Class II Director
February 20, 2015 10:05 PM ET
Spectrum Brands Holdings, Inc. Elects Joseph S. Steinberg as Director
February 20, 2015 9:11 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact miRagen Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.